SeaStar Medical Holding Corp (ICU)
0.5172
0.00 (0.00%)
USD |
NASDAQ |
Apr 30, 13:01
SeaStar Medical Cash from Financing (TTM): 10.41M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.41M |
| September 30, 2023 | 11.13M |
| June 30, 2023 | 10.08M |
| March 31, 2023 | 10.02M |
| Date | Value |
|---|---|
| December 31, 2022 | 7.331M |
| September 30, 2022 | 2.512M |
| June 30, 2022 | 2.161M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
2.161M
Minimum
Jun 2022
11.13M
Maximum
Sep 2023
7.663M
Average
10.02M
Median
Mar 2023
Cash from Financing (TTM) Benchmarks
| Nuwellis Inc | 3.683M |
| Ardelyx Inc | 146.30M |
| Adverum Biotechnologies Inc | 0.069M |
| Aquestive Therapeutics Inc | 3.974M |
| Vir Biotechnology Inc | 7.48M |